Award of NDPP Framework Call-Off for Behavioural Interventions to Prevent Type 2 Diabetes

About

NHS COMMISSIONING BOARD awarded a contract to Reed Momenta for the delivery of between 10,000 and 100,000 behavioural interventions aimed at preventing or delaying the onset of Type 2 diabetes in people with non-diabetic hyperglycaemia (pre-diabetes) over the 3-year term of the NDPP Framework Agreement, with an estimated value of AUD 680,000.

The contract anticipates up to 30,000 interventions in year 1, up to 60,000 in year 2, and up to 100,000 in year 3, with quantities subject to variation.

The primary aim is to reduce the incidence of Type 2 diabetes in the referred cohort, while secondary aims include reducing blood glucose parameters (HbA1c or Fasting Plasma Glucose) and weight at 12 months and beyond, and maximising programme completion rates.

A tertiary aim is to establish sound data collection mechanisms to assess programme effectiveness in reducing long-term microvascular and cardiovascular complications and associated mortality risk.